When the three HCC cell lines challenged with chemotherapeutic doxorubicin at sensitive dosing of 0.5 and 1 μM which were determined previously, there were significant changes in EpCAM expression at both mRNA and protein levels. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.